International Biotechnology Trust’s Ironwood Pharmaceuticals IRWD Stock Holding History

International Biotechnology Trust’s Portfolio IRWD Stock Details IRWD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-60,000	Closed	-$631K	–	72
2023 Q1	$631K	Hold	60,000	–	–	0.18%	57
2022 Q4	$743K	Hold	60,000	–	–	0.23%	56
2022 Q3	$621K	Buy	60,000 +59,308	+8,571%	+$672K	0.2%	58
2022 Q2	$60K	Buy	+692	New	+$8.15K	0.63%	37
2017 Q4	–	Sell	-70,446	Closed	-$930K	–	68
2017 Q3	$930K	Hold	70,446	–	–	0.36%	47
2017 Q2	$1.11M	Hold	70,446	–	–	0.42%	47
2017 Q1	$1.01M	Hold	70,446	–	–	0.39%	50
2016 Q4	$903K	Buy	+70,446	New	+$890K	0.41%	38

Other funds holding IRWD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

International Biotechnology Trust's IRWD Position: Q2 2023 in Review

International Biotechnology Trust sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2023, closing a stake of 60,000 shares — an estimated $631K sold.

International Biotechnology Trust first reported a position in IRWD in Q4 2016 and held it in 8 quarters. The position peaked at $1.11M in Q2 2017. 252 funds tracked by Wall St. Rank hold IRWD as of Q2 2023.

International Biotechnology Trust reported no remaining Ironwood Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
International Biotechnology Trust sold 60,000 Ironwood Pharmaceuticals shares in Q2 2023, an estimated $631K.
International Biotechnology Trust first reported a position in Ironwood Pharmaceuticals in Q4 2016 and held it in 8 quarters.
International Biotechnology Trust's Ironwood Pharmaceuticals position peaked at $1.11M in Q2 2017.
252 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2023.

Based on International Biotechnology Trust's 13F filing for Q2 2023, filed 8 Aug 2023.